Avertix Medical appoints Meredith to board of directors

Avertix Medical announced today that Professor Ian Meredith AM, has agreed to join the Company’s Board of Directors following the closing of the Company’s previously announced business combination with BIOS Acquisition Corporation (BIOS). Professor Meredith recently retired from Boston Scientific (BSX) after serving over six years as its Executive Vice President and Global Chief Medical Officer, where he was responsible for global leadership of medical, clinical science and trial strategy across the organization.